Replimune Group, Inc. (REPL)
NASDAQ: REPL · IEX Real-Time Price · USD
28.62
+0.46 (1.63%)
Feb 7, 2023, 4:00 PM EST - Market closed
REPL Market Cap
Replimune Group has a market cap or net worth of $1.58 billion as of February 8, 2023. Replimune Group's market cap has increased by 44.33% in one year.
Market Cap
1.58B
Enterprise Value
1.24B
1-Year Change
44.33%
Ranking
Category
Stock Price
$28.62
Market Cap Chart
Since July 20, 2018, Replimune Group, Inc.'s market cap has increased from $835.53M to $1.58B, an increase of 88.79%. That is a compound annual growth rate of 14.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 7, 2023 | 1.58B | 1.63% |
Feb 6, 2023 | 1.55B | -0.46% |
Feb 3, 2023 | 1.56B | -2.75% |
Feb 2, 2023 | 1.60B | 1.75% |
Feb 1, 2023 | 1.58B | 2.66% |
Jan 31, 2023 | 1.53B | 7.82% |
Jan 30, 2023 | 1.42B | -0.23% |
Jan 27, 2023 | 1.43B | -0.92% |
Jan 26, 2023 | 1.44B | -6.68% |
Jan 25, 2023 | 1.54B | -2.71% |
Jan 24, 2023 | 1.59B | 4.58% |
Jan 23, 2023 | 1.52B | 0.33% |
Jan 20, 2023 | 1.51B | 0.55% |
Jan 19, 2023 | 1.50B | -0.26% |
Jan 18, 2023 | 1.51B | -1.55% |
Jan 17, 2023 | 1.53B | -1.00% |
Jan 13, 2023 | 1.55B | 2.45% |
Jan 12, 2023 | 1.51B | 3.75% |
Jan 11, 2023 | 1.46B | -0.86% |
Jan 10, 2023 | 1.47B | 4.47% |
Jan 9, 2023 | 1.40B | -1.28% |
Jan 6, 2023 | 1.42B | 0.27% |
Jan 5, 2023 | 1.42B | -1.90% |
Jan 4, 2023 | 1.45B | -0.38% |
Jan 3, 2023 | 1.45B | -3.13% |
View and export this data all the way back to 2018.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Deciphera Pharmaceuticals, Inc. | 1.27B |
Cross Country Healthcare, Inc. | 1.16B |
uniQure N.V. | 1.05B |
POINT Biopharma Global, Inc. | 838.82M |
Editas Medicine, Inc. | 774.27M |
Theravance Biopharma, Inc. | 717.45M |
Erasca, Inc. | 652.73M |
Cardiovascular Systems, Inc. | 616.51M |
Design Therapeutics, Inc. | 447.84M |
Pulmonx Corporation | 329.58M |